Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer

E-ISSN： 1873-5576|14|9|775-793

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.14, Iss.9, 2014-11, pp. : 775-793

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of erbB-1 kinase

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 12, 2002-12 ,pp. : 1903-1907

Informa Healthcare

Access to resources Recommend Favorite

Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy

Current Medicinal Chemistry, Vol. 19, Iss. 4, 2012-02 ,pp. : 475-487

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM proteases, ErbB pathways and cancer

By Zhou Bin-Bing S Fridman Jordan S Liu Xiangdong Friedman Steve M Newton Robert C Scherle Peggy A

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 591-606

Informa Healthcare

Access to resources Recommend Favorite

The ErbB Receptors and their Ligands in Cancer: An Overview

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 243-257

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: ErbB Family and Downstream Signal Transduction Pathways as Targets for Anticancer Therapy (Guest Editor: F. Caponigro)]

Current Drug Targets, Vol. 6, Iss. 3, 2005-05 ,pp. : 241-242

Bentham Science Publishers

Access to resources Recommend Favorite